LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial.
Saved in:
| Title: | LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial. |
|---|---|
| Authors: | Guan, Kai1 (AUTHOR), Liu, Shuang1 (AUTHOR), Feng, Yan2 (AUTHOR), Li, Lisha1 (AUTHOR), Zhu, Xiaoming3 (AUTHOR), Bill, Nai‐Chau‐Sun4 (AUTHOR), Ma, Haili4 (AUTHOR), Yang, Jie4 (AUTHOR), Han, Cuicui4 (AUTHOR), Liu, Heng4 (AUTHOR), Wei, Qingyu3 (AUTHOR) weiqingyu1964@163.com, Shi, Haiyun5 (AUTHOR) shydftg@126.com, Wang, Xueyan5 (AUTHOR) wangxueyan2018@163.com |
| Source: | Clinical & Translational Allergy. Jun2025, Vol. 15 Issue 6, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
